EUVIMEDEUVIMED entdecken
Crossref

Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO‐1 Pathways

Jinxiang Huang, Qixuan Li, Hongxiang Wang, Shuai Zhang, Xiaorong Zhou, Fang Huang, Juxiang Chen, Luning Xu, Dezhi Kang

The Journal of Gene Medicine · 2025-02 · 27 (2)

DOI: 10.1002/jgm.70011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, online erschienen am 18.02.2025. Verfasst von Jinxiang Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Pentacyclic Triterpenes, Ferroptosis, NF-E2-Related Factor 2, Glioma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gliomas currently have a poor prognosis and limited therapy options. Betulinic acid (BA) has demonstrated antitumor activity in various cancers. This study is aimed at clarifying the underlying mechanisms by which BA inhibits gliomas.

Methods

We assessed how BA affected the migration, apoptosis, invasion, proliferation, and viability of U251 glioma cells. The genes that were differentially expressed after BA treatment were identified via RNA sequencing. Utilizing Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes, research was done to determine the affected pathways. Molecular docking was applied to explore the interaction of BA with key pathway molecules. Experimental assays were conducted to confirm the impact of BA on these pathways and targets.

Results

In U251 cells, BA reduced viability; inhibited colony formation, migration, and invasion; and triggered apoptosis. Through RNA sequencing, 923 up‐ and 1469 downregulated genes were found, with notable enrichment in the TNF, PI3K‐Akt, and ferroptosis pathways. BA can stably bind to TNF and PI3K‐Akt pathway molecules, especially AKT1 (binding energy = −10.2 kcal/mol). BA administration decreased the levels of phosphorylated PI3K and AKT. Moreover, BA‐induced ferroptosis and HO‐1 and NRF2 levels were increased. Ferrostatin‐1 and zinc protoporphyrin pretreatment decreased intracellular iron and lipid peroxidation and decreased the decrease in cell viability caused by BA.

Conclusions

BA controls the PI3K/Akt and NRF2/HO‐1 pathways, which results in glioma ferroptosis. Understanding BA's multipathway mechanism may inform its therapeutic potential in glioma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pentacyclic TriterpenesFerroptosisNF-E2-Related Factor 2GliomaProto-Oncogene Proteins c-aktSignal TransductionHeme Oxygenase-1HumansBetulinic AcidCell Line, TumorPhosphatidylinositol 3-KinasesCell ProliferationGene Expression Regulation, NeoplasticCell MovementMolecular Docking SimulationApoptosisCell SurvivalDisease Progression

Stichwörter der Autor:innen

NRF2/HO‐1 pathwayPI3K/Akt pathwaybetulinic acidferroptosisgliomamolecular docking

Substanzen

Betulinic AcidPentacyclic TriterpenesNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktHeme Oxygenase-1Phosphatidylinositol 3-KinasesNFE2L2 protein, humanHMOX1 protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Department of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Naval Medical University (Changhai Hospital), Shanghai, China.
  • Department of Clinical Pharmacy, Sanming First Hospital, Fujian Medical University, Sanming, China.
  • Fujian Institute of Brain Disorders and Brain Science, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

Förderung

  • Natural Science Foundation of Fujian Province

Zitieren

APA

Huang, J., Li, Q., Wang, H., Zhang, S., Zhou, X., Huang, F., Chen, J., Xu, L., & Kang, D. (2025). Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO‐1 Pathways. The Journal of Gene Medicine, 27(2). https://doi.org/10.1002/jgm.70011

Vancouver

Huang J, Li Q, Wang H, Zhang S, Zhou X, Huang F, et al. Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO‐1 Pathways. The Journal of Gene Medicine. 2025;27(2). doi:10.1002/jgm.70011

BibTeX
@article{Huang2025,
  author = {Huang, Jinxiang and Li, Qixuan and Wang, Hongxiang and Zhang, Shuai and Zhou, Xiaorong and Huang, Fang and Chen, Juxiang and Xu, Luning and Kang, Dezhi},
  title = {Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO‐1 Pathways},
  journal = {The Journal of Gene Medicine},
  year = {2025},
  volume = {27},
  number = {2},
  doi = {10.1002/jgm.70011}
}
Kostenlos starten →